What Do You Really Know About Psychedelics And Psychedelics Stocks?
According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha.
In just a couple of years, psychedelics took the world of investing by storm.
89bio Says Completed Target Enrollment In Histology Cohort To Evaluate BIO89-100 For Treatment Of NASH
89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced
Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics
Psychedelics biotech company Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:1XU1) has acquired Lobo Genetics Inc., a Canadian personalized genetics company with a psychedelics and cannabis-focused direct-to-consumer platform, in an all-stock deal.